210 related articles for article (PubMed ID: 37409509)
1. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia.
Morse AM; Dauvilliers Y; Arnulf I; Thorpy MJ; Foldvary-Schaefer N; Chandler P; Chen A; Hickey L; Black J; Bogan RK
J Clin Sleep Med; 2023 Oct; 19(10):1811-1822. PubMed ID: 37409509
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
Dauvilliers Y; Arnulf I; Foldvary-Schaefer N; Morse AM; Šonka K; Thorpy MJ; Mignot E; Chandler P; Parvataneni R; Black J; Sterkel A; Chen D; Skobieranda F; Bogan RK
Lancet Neurol; 2022 Jan; 21(1):53-65. PubMed ID: 34942138
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Bogan RK; Foldvary-Schaefer N; Skowronski R; Chen A; Thorpy MJ
CNS Drugs; 2023 Apr; 37(4):323-335. PubMed ID: 36947322
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia.
Thorpy MJ; Arnulf I; Foldvary-Schaefer N; Morse AM; Šonka K; Chandler P; Hickey L; Chen A; Black J; Sterkel A; Chen D; Bogan RK; Dauvilliers Y
Nat Sci Sleep; 2022; 14():1901-1917. PubMed ID: 36320423
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
Lecendreux M; Plazzi G; Dauvilliers Y; Rosen CL; Ruoff C; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
J Clin Sleep Med; 2022 Sep; 18(9):2217-2227. PubMed ID: 35689598
[TBL] [Abstract][Full Text] [Related]
6. Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav
Heo YA
CNS Drugs; 2022 May; 36(5):541-549. PubMed ID: 35357671
[TBL] [Abstract][Full Text] [Related]
7. Medications for daytime sleepiness in individuals with idiopathic hypersomnia.
Trotti LM; Becker LA; Friederich Murray C; Hoque R
Cochrane Database Syst Rev; 2021 May; 5(5):CD012714. PubMed ID: 34031871
[TBL] [Abstract][Full Text] [Related]
8. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Dauvilliers Y; Šonka K; Bogan RK; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Chen A; Black J; Skobieranda F; Thorpy MJ
CNS Drugs; 2022 Jun; 36(6):633-647. PubMed ID: 35635687
[TBL] [Abstract][Full Text] [Related]
9. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
[TBL] [Abstract][Full Text] [Related]
10. Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion.
Arnulf I; Thomas R; Roy A; Dauvilliers Y
Sleep Med Rev; 2023 Jun; 69():101766. PubMed ID: 36921459
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy.
Bogan RK; Thorpy MJ; Dauvilliers Y; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Tang L; Skobieranda F; Šonka K
Sleep; 2021 Mar; 44(3):. PubMed ID: 33184650
[TBL] [Abstract][Full Text] [Related]
12. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study.
Inoue Y; Tabata T; Tsukimori N
Sleep Med; 2021 Apr; 80():315-321. PubMed ID: 33631500
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy.
Dauvilliers Y; Lammers GJ; Lecendreux M; Maski K; Kansagra S; Black J; Parvataneni R; Chen A; Wang YG; Plazzi G
J Clin Sleep Med; 2024 Mar; 20(3):445-454. PubMed ID: 37942930
[TBL] [Abstract][Full Text] [Related]
15. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
Menn SJ; Yang R; Lankford A
J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
[TBL] [Abstract][Full Text] [Related]
16. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension.
Ivgy-May N; Hajak G; van Osta G; Braat S; Chang Q; Roth T
J Clin Sleep Med; 2020 Sep; 16(9):1455-1467. PubMed ID: 32351205
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
Weaver TE; Pepin JL; Schwab R; Shapiro C; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Bron M; Chandler P; Lee L; Malhotra A
J Clin Sleep Med; 2021 Oct; 17(10):1995-2007. PubMed ID: 34606437
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and their consequences in idiopathic hypersomnia.
Rassu AL; Evangelista E; Barateau L; Chenini S; Lopez R; Jaussent I; Dauvilliers Y
J Clin Sleep Med; 2022 Feb; 18(2):617-629. PubMed ID: 34596041
[TBL] [Abstract][Full Text] [Related]
20. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
